Atlas company financials

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Standardized 18-year financial series for CHARLES RIVER LABORATORIES INTERNATIONAL, INC., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001100682FY2008 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$4B

Adjusted EBITDA

—

Net result

-$144.3M

Net financial debt

-$213.6M

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$1B

TTM revenue

$4B

TTM free cash flow

—

Latest quarter net result

$54.4M

Quarterly coverage: 50 periods · latest quarter FY2025-Q3 · TTM revenue growth -2.3%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · charles-river-laboratories-international-inc-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-23 · Retrieved: 2026-04-26T11:49:30.250739+00:00
SEC EDGAR companyfacts
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · us gaap companyfacts · comparative · charles-river-laboratories-international-inc-fy2009 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-27 · Retrieved: 2026-04-26T11:49:30.250739+00:00
SEC EDGAR companyfacts
us-gaap:CapitalExpendituresIncurredButNotYetPaid · us gaap companyfacts · comparative · charles-river-laboratories-international-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-25 · Retrieved: 2026-04-26T11:49:30.250739+00:00
SEC EDGAR companyfacts
primary · charles-river-laboratories-international-inc-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:49:30.250739+00:00
SEC EDGAR companyfacts

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2008	1B	—	-452M	-525M	276M	—	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing capex · missing current assets · missing current liabilities · missing diluted weighted average shares · missing free cash flow · missing gross profit · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2009	1B	—	170M	114M	216M	—	—	comparative annual fact carried from later 10k · missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit · missing net financial debt · missing research and development
FY2010	1B	—	-299M	-337M	168M	—	522M	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit · missing research and development
FY2011	1B	—	174M	—	207M	-5M	649M	missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2012	1B	—	166M	—	208M	-3M	278M	missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2013	1B	—	151M	103M	209M	-7M	507M	missing adjusted ebitda · missing gross profit · missing research and development
FY2014	1B	—	178M	127M	252M	-4M	594M	missing adjusted ebitda · missing gross profit · missing research and development

Filing provenance